Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our lung transplant and lung cancer programs are leading the nation in discoveries of new treatments and development of new procedures, and our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. The Division of Pulmonology, Critical Care and Sleep Medicine at The Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2024-25.
Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our lung transplant and lung cancer programs are leading the nation in discoveries of new treatments and development of new procedures, and our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. The Division of Pulmonology, Critical Care and Sleep Medicine at The Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2024-25.
Mount Sinai researchers are exploring the finding that certain proteins produced by patients with mild to moderate eosinophilic asthma downregulate the angiotensin-converting enzyme 2 receptor that allows SARS-CoV-2 entry to airway cells, ...
Through two innovative research projects that weave highly detailed satellite data on temperature, humidity, and air pollution together with patient medical records and hospital admission data to better understand the relationship between ...
The study, the largest of its kind, found that patients with long COVID may exhibit inflammation in the heart and lungs for up to a year after SARS-CoV-2 infection.
The Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine provides state-of-the-art consultation, diagnostic testing, and clinical and multidisciplinary care to patients with simple and complex respiratory ...
From an expanding lung transplantation service to a new pulmonary rehabilitation program and increased asthma research, the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine propelled the full range ...
The Mount Sinai Health System's Asian Thoracic Surgery Program has an urgent new mission: diagnosing, treating, and investigating a phenomenon known as never-smoking lung cancer, which disproportionately affects Asian women. A major challenge ...
The Mount Sinai Health System has launched an integrated pulmonary hypertension program that brings cardiologists and pulmonologists together to tackle all five subgroups of the chronic, progressive, and potentially fatal disorder.
A Mount Sinai researcher has founded a regional research consortium to pool the work of some of the top labs in the field to promote a better understanding of CFTR, a protein implicated in cystic fibrosis, and how it could lead to new ...
A new Mount Sinai program takes a holistic, multidisciplinary approach to managing obstructive sleep apnea (OSA) among patients with obesity. It is a timely undertaking, not only because the prevalence of obesity is rising in the United ...
Mount Sinai Health System recently opened a comprehensive pulmonary rehabilitation program geared to patients with exercise limitations attributable to the lung or other organs. It offers them 8 to 12 weeks of muscle strengthening, helpful ...
Sleep researchers at Mount Sinai have made a major breakthrough by developing a new model that analyzes sleep study data using generative artificial intelligence. This advance provides a robust profile of patient risk for not just cardiovascular ...
For patients with pleural mesothelioma, having a higher sum of maximum pleural thickness at three specific levels measured in the axial plane predicts worse survival. This finding informs the forthcoming ninth edition of the TNM Staging ...
A pneumatocele that occupied almost the entirety of Baby P’s right lower lung was becoming life-threatening. But with help from the Chronic Lung Care team at Mount Sinai Kravis Children’s Hospital, he is now doing well.
Mount Sinai Health System is taking a systematic approach to addressing incidental lung nodules. It includes using natural language processing to scan all Mount Sinai Morningside and Mount Sinai West chest-related radiological reports ...
The Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine provides state-of-the-art consultation, diagnostic testing, and clinical and multidisciplinary care to patients with simple and complex respiratory ...
Interventional bronchoscopy has long been part of the adult pulmonologist's armamentarium; however, it is rarely used in children for a variety of reasons. But at Mount Sinai Kravis Children’s Hospital, interventional bronchoscopy has ...
The new Mount Sinai Multispecialty Lung Nodules Diagnostic and Treatment Program and an in-depth look at our revitalized bronchiectasis program, which also offers patients a range of medical and surgical options, are among the highlights of this year's report.
Despite advances in lung cancer treatment, the disease remains deadly, with the stage of lung cancer at the time of detection being a major determinant in survival. To improve early diagnosis and treatment, the Mount Sinai – National Jewish ...
Robotic-assisted surgery, early intervention, and a comprehensive patient registry are among the ways in which Mount Sinai’s bronchiectasis program continues to distinguish itself in the diagnosis and treatment of the disease. Launched ...
A Mount Sinai surgeon has developed a unique three-incision robotic surgical technique for conducting minimally invasive first-rib resections that he says is safer, more effective, and easily reproducible.
A new study by researchers at the Icahn School of Medicine at Mount Sinai has unraveled the intricate molecular interplay between systemic processes within the blood and localized processes within the airways of individuals with asthma.
Mount Sinai researchers have developed a novel, automated measure of analyzing sleep studies to determine the severity and risk of mortality in patients with obstructive sleep apnea, a chronic sleep disorder that affects about 30 million ...
The Mount Sinai Respiratory Institutes is offering a 2 day comprehensive course on advanced topics in pulmonary medicine, directed toward community pulmonologists, advanced practice NP and PA providers as well primary care physicians.
Influenza infection (flu) is a major cause of death around the world, especially during years of flu pandemics. People who die of the flu often have a secondary lung infection with Staphylococcus aureus (staph) bacteria that starts a few ...
Mount Sinai Health System is using custom 3D-printed stents to open the trachea and main bronchi of patients with complex airway anatomy. Over time, an interventional pulmonologist believes, they could replace standard stenting for benign ...
A new Mount Sinai research program aims to map the developing pediatric airway from minimally invasive respiratory samples obtained during flexible bronchoscopy, with the goal of advancing cystic fibrosis therapeutics and enabling the ...
A first-of-its-kind study led by a Mount Sinai researcher suggests that even a brief withdrawal of continuous positive airway pressure therapy for sleep apnea might increase one’s risk of developing Alzheimer’s disease.
Mount Sinai’s Scott Scheinin, MD, and Harish Seethamraju, MD, are establishing the End-Stage Lung Disease and Transplant Program as a leader in treating complex cases.
Mount Sinai has launched a novel technology-driven teaching scholars curriculum that uses a blended learning model to prepare subspecialty pulmonary and critical care fellows for careers as clinician-educators.
Mount Sinai is undertaking several initiatives to better understand the factors that contribute to severe asthma and identify different subtypes of the disease. The work is intended to bring a precision medicine approach to asthma.
The Mount Sinai – National Jewish Health Respiratory Institute’s Pleural Service, launched in 2020, has used pleuroscopy to dramatically increase its reach and the number and acuity of patients it can serve.
A Mount Sinai physician has developed an algorithm that uses a range of electronic medical record data to identify patients who are ready to be liberated from ventilation.
